QuidelOrtho Corporation announced the appointment of Erich Wolff as Executive Vice President, Strategy & Corporate Development, effective August 19, 2025. In this role, Mr. Wolff will report directly to President and CEO Brian Blaser and will lead the company's enterprise strategy, business development, government affairs, and portfolio management functions.
Mr. Wolff brings over two decades of leadership experience in strategy, M&A, and business development across the healthcare, diagnostics, and MedTech sectors. His previous roles include Buyouts Lead for MedTech and Life Sciences Tools & Diagnostics at Partners Group, and senior leadership positions at BD and Medtronic.
His expertise in driving complex portfolio decisions and executing high-impact growth strategies is expected to be invaluable as QuidelOrtho continues to advance its diagnostics business. This appointment signals a strengthened focus on strategic growth and inorganic expansion.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.